Zelsuvmi is a topical gel applied to molluscum contagiosum skin lesions in patients aged one year and older. The gel releases nitric oxide to clear lesions and is the only at-home prescription treatment for this viral infection.
Approval Date
05-Jan-24
NCE-1 Date
05-Jan-28
NCE Date
05-Jan-29
Commercial snapshot
Market performance & projections
Revenue ($M)
NA
CAGR (%)
NA
Projected sales, 2026–2032 ($M)
Analyst projection, $M per year
2026
6
2027
13
2028
17
2029
24
2030
29
2031
35
2032
40
Molecule profile
Details & specifications
Molecule
Berdazimer
Innovator
LNHC INC
Dosage Form
Topical Gel
Strength
EQ 10.3% base
Therapeutic Category
Antiviral
Usage
To treat molluscum contagiosum
Good to know
Frequently asked questions
Ready to act on this opportunity?
Talk to Spring Bio Solution about sourcing, licensing, and filing support for this molecule.